Research
1- Phase II Evaluation of AHCC for the Eradication of HPV Infections (AHCC4HPV)
https://clinicaltrials.gov/ct2/show/NCT02405533?cond=ahcc+hpv&draw=2&rank=1
2- Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese Female
https://clinicaltrials.gov/ct2/show/NCT04633330?cond=ahcc&draw=2&rank=3
3- A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC
https://clinicaltrials.gov/ct2/show/NCT02405533?cond=ahcc+hpv&draw=2&rank=1
2- Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese Female
https://clinicaltrials.gov/ct2/show/NCT04633330?cond=ahcc&draw=2&rank=3
3- A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC